GlassScriptPhysician profile
Joshua Horton
NPI 1992153076
$3,750.70
in general payments reported to CMS, 2019-2025
13 companies · $31.09 in 2025
The $31.09 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.21 · 2020: $109 · 2021: $2,218 · 2022: $720 · 2023: $179 · 2024: $398 · 2025: $31.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,898.58 | 2021-2025 | Inspire |
| Stryker Corporation | $1,014.37 | 2020-2022 | |
| Acera Surgical, INC. | $147.41 | 2024 | Restrata Wound Matrix |
| Baxter Healthcare | $136.13 | 2023 | |
| Smith+Nephew, INC. | $120.00 | 2021 | |
| Genzyme Corporation | $109.68 | 2022 | |
| Ethicon US, LLC | $95.21 | 2019 | |
| Medtronic, INC. | $93.26 | 2021 | |
| Polynovo North America LLC | $36.95 | 2023-2024 | Novosorb Btm |
| Karl Storz Endoscopy-America | $30.74 | 2021 | |
| Ambu INC. | $30.73 | 2024 | |
| Forte Bio-Pharma LLC | $23.15 | 2023 | Prolate, Nalocet |
| Acclarent, INC | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Horton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.